ComplianceOnline

USDA biotech regulations on

  • Date: November 02, 2009
  • Source: www.current.com
Webinar All Access Pass Subscription Abstract:

U. S. Department of Agriculture’s newly proposed rule governing genetically engineered crops, including food crops engineered to produce pharmaceutical and industrial products came under severe opposition by the Union of concerned scientists. The charge is that the rule does not protect the U. S. food supply from contamination by drugs from “pharma” crops. There seems to be a contamination by way of cross-pollination or seed mixing between pharma food crops and crops intended for consumption.

Recommendations from various like minded organizations such as UCS and Grocery Manufacturers Association to ban outdoor production of pharma food crops have been ignored by USDA. The new proposal also does not offer any incentives for pharma companies to follow already existing safer methods of producing drugs.

USDA has also left a very small window for public participation in its rush to enact this rule into law.

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading